Actionable news
All posts from Actionable news
Actionable news in NLNK: NewLink Genetics Corporation,

NewLink Genetics (NLNK) In A Perilous Reversal

Trade-Ideas LLC identified NewLink Genetics ( NLNK) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified NewLink Genetics as such a stock due to the following factors:

  • NLNK has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $27.6 million.
  • NLNK has traded 53,444 shares today.
  • NLNK is down 5.1% today.
  • NLNK was up 6.5% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in NLNK with the Ticky from Trade-Ideas. See the FREE profile for NLNK NOW at Trade-Ideas More details on NLNK: NewLink Genetics Corporation, a biopharmaceutical company, focuses on discovering, developing, and commercializing immunotherapeutic products to enhance treatment options for patients with cancer. NLNK has a PE ratio of 9. Currently there are 2 analysts that rate NewLink Genetics a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for NewLink Genetics has been 529,600 shares per day over the past 30 days. NewLink has a market cap of $965.6 million and is part of the health care sector and drugs...